The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
100408856 10040885 6 F 2014 20160829 20140327 20160831 PER US-PFIZER INC-2014083425 PFIZER 63.00 YR F Y 81.63000 KG 20160831 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
100408856 10040885 1 PS LYRICA PREGABALIN 1 Oral 2X/DAY (ONE IN THE MORNING AND TWO AT NIGHT) 21446 CAPSULE, HARD BID
100408856 10040885 2 SS LYRICA PREGABALIN 1 Oral 225 MG, 2X/DAY 21446 225 MG CAPSULE, HARD BID
100408856 10040885 3 SS LYRICA PREGABALIN 1 21446 CAPSULE, HARD
100408856 10040885 4 C ACETAMINOPHEN/HYDROCODONE ACETAMINOPHENHYDROCODONE 1 UNK [HYDROCODONE BITARTRATE10]/[PARACETAMOL 325] 0
100408856 10040885 5 C MORPHINE MORPHINE 1 30 MG, UNK (30MG ER X1) 0 30 MG
100408856 10040885 6 C HYDROCODONE HYDROCODONE 1 325 MG ONCE EVERY FOUR HOURS AS NEEDED 0 325 MG
100408856 10040885 7 C MS CONTIN MORPHINE SULFATE 1 30 MG, 2X/DAY 0 30 MG PROLONGED-RELEASE TABLET BID
100408856 10040885 8 C NORCO ACETAMINOPHENHYDROCODONE BITARTRATE 1 Oral [HYDROCODONE BITARTRATE 10 MG]/ [PARACETAMOL 325 MG] EVERY 6-8 HOURS AS NEEDED 0 TABLET
100408856 10040885 9 C AMITRIPTYLINE AMITRIPTYLINE 1 Oral 50 MG, 1X/DAY (NIGHTLY) 0 50 MG TABLET QD
100408856 10040885 10 C ASPIRIN 81 ASPIRIN 1 81 MG, UNK (81MG X1) 0 81 MG PROLONGED-RELEASE TABLET
100408856 10040885 11 C PANTOPRAZOLE PANTOPRAZOLE SODIUM 1 Intravenous (not otherwise specified) 40 MG, UNK (40MG X1) 0 40 MG SOLUTION FOR INJECTION
100408856 10040885 12 C CALCIUM CALCIUM 1 600 MG, UNK (600MG X2) 0 600 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
100408856 10040885 1 Neuralgia
100408856 10040885 2 Fibromyalgia
100408856 10040885 3 Neuropathy peripheral
100408856 10040885 5 Pain
100408856 10040885 6 Pain
100408856 10040885 7 Pain
100408856 10040885 8 Pain

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
100408856 10040885 Burning sensation
100408856 10040885 Neuralgia
100408856 10040885 Pain
100408856 10040885 Pain in extremity

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found